{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:57:26Z","timestamp":1785491846607,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016209","name":"Bilimsel Ara\u015ft\u0131rma Projeleri, Erciyes \u00dcniversitesi","doi-asserted-by":"publisher","award":["TSA-2023-13015"],"award-info":[{"award-number":["TSA-2023-13015"]}],"id":[{"id":"10.13039\/501100016209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02396-7","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:34:54Z","timestamp":1785137694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of body composition, irisin, and FABP4 levels in adolescent girls with polycystic ovary syndrome"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5261-9222","authenticated-orcid":false,"given":"Leyla","family":"Kara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-3498","authenticated-orcid":false,"given":"Ulku Gul","family":"Siraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-2620","authenticated-orcid":false,"given":"Sabahattin","family":"Muhtaroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9860-4010","authenticated-orcid":false,"given":"Neslihan","family":"Sungur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-6539","authenticated-orcid":false,"given":"Nihal","family":"Hatipoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"6","key":"2396_CR1","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745\u20139. https:\/\/doi.org\/10.1210\/jc.2003-032046.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2396_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004.","journal-title":"Fertil Steril"},{"issue":"10","key":"2396_CR3","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447\u201369. https:\/\/doi.org\/10.1210\/clinem\/dgad463.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2396_CR4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774\u2013800. https:\/\/doi.org\/10.1210\/edrv.18.6.0318.","journal-title":"Endocr Rev"},{"key":"2396_CR5","doi-asserted-by":"publisher","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012 Nov-Dec;18(6):618\u201337. https:\/\/doi.org\/10.1093\/humupd\/dms030.","DOI":"10.1093\/humupd\/dms030"},{"issue":"10","key":"2396_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","volume":"126","author":"JP Despr\u00e9s","year":"2012","unstructured":"Despr\u00e9s JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation. 2012;126(10):1301\u201313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.067264.","journal-title":"Circulation"},{"issue":"9","key":"2396_CR7","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/humrep\/den211","volume":"23","author":"PF Svendsen","year":"2008","unstructured":"Svendsen PF, Nilas L, N\u00f8rgaard K, Jensen JE, Madsbad S. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod. 2008;23(9):2113\u201321. https:\/\/doi.org\/10.1093\/humrep\/den211.","journal-title":"Hum Reprod"},{"issue":"5","key":"2396_CR8","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.clnu.2004.06.004","volume":"23","author":"UG Kyle","year":"2004","unstructured":"Kyle UG, et al. Bioelectrical impedance analysis\u2013part I: review of principles and methods. Clin Nutr. 2004;23(5):1226\u201343. https:\/\/doi.org\/10.1016\/j.clnu.2004.06.004.","journal-title":"Clin Nutr"},{"issue":"2","key":"2396_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/ajcn\/77.2.331","volume":"77","author":"SS Sun","year":"2003","unstructured":"Sun SS, et al. Development of bioelectrical impedance analysis prediction equations for body composition with the use of a multicomponent model for use in epidemiologic surveys. Am J Clin Nutr. 2003;77(2):331\u201340. https:\/\/doi.org\/10.1093\/ajcn\/77.2.331.","journal-title":"Am J Clin Nutr"},{"issue":"6 Pt A","key":"2396_CR10","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.clnu.2017.09.021","volume":"37","author":"J Xiao","year":"2018","unstructured":"Xiao J, Purcell SA, Prado CM, Gonzalez MC. Fat mass to fat-free mass ratio reference values from NHANES III using bioelectrical impedance analysis. Clin Nutr. 2018;37(6 Pt A):2284\u20137. https:\/\/doi.org\/10.1016\/j.clnu.2017.09.021.","journal-title":"Clin Nutr"},{"issue":"2","key":"2396_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/cdt3.54","volume":"9","author":"X He","year":"2023","unstructured":"He X, et al. Percent body fat, but not body mass index, is associated with cardiometabolic risk factors in children and adolescents. Chronic Dis Transl Med. 2023;9(2):143\u201353. https:\/\/doi.org\/10.1002\/cdt3.54.","journal-title":"Chronic Dis Transl Med"},{"issue":"1","key":"2396_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12902-019-0381-4","volume":"19","author":"LE McBreairty","year":"2019","unstructured":"McBreairty LE, Chilibeck PD, Gordon JJ, Chizen DR, Zello GA. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study. BMC Endocr Disord. 2019;19(1):70. https:\/\/doi.org\/10.1186\/s12902-019-0381-4.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"2396_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/jcm13020483","volume":"13","author":"J Cai","year":"2024","unstructured":"Cai J, et al. Association of Fat Mass and Skeletal Muscle Mass with Cardiometabolic Risk Varied in Distinct PCOS Subtypes: A Propensity Score-Matched Case-Control Study. J Clin Med. 2024;13(2):483. https:\/\/doi.org\/10.3390\/jcm13020483.","journal-title":"J Clin Med"},{"issue":"6","key":"2396_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1515\/jpem-2020-0533","volume":"34","author":"Q Yang","year":"2021","unstructured":"Yang Q, Ma P, Zhang H, Cai R, Dong Y, Ding W. Body fat distribution in trunk and legs are associated with cardiometabolic risk clustering among Chinese adolescents aged 10\u201318 years old. J Pediatr Endocrinol Metab. 2021;34(6):721\u20136. https:\/\/doi.org\/10.1515\/jpem-2020-0533.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7382","key":"2396_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m P, et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463\u20138. https:\/\/doi.org\/10.1038\/nature10777.","journal-title":"Nature"},{"key":"2396_CR16","doi-asserted-by":"publisher","first-page":"962968","DOI":"10.3389\/fendo.2022.962968","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu S, Cui F, Ning K, Wang Z, Fu P, Wang D, Xu H. Role of irisin in physiology and pathology. Front Endocrinol (Lausanne). 2022;13:962968. https:\/\/doi.org\/10.3389\/fendo.2022.962968.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"23","key":"2396_CR17","first-page":"4462","volume":"19","author":"MS Bostanc\u0131","year":"2015","unstructured":"Bostanc\u0131 MS, Akdemir N, Cinemre B, Cevrioglu AS, \u00d6zden S, \u00dcnal O. Serum irisin levels in patients with polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2015;19(23):4462\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"2396_CR18","doi-asserted-by":"publisher","first-page":"E2539","DOI":"10.1210\/jc.2014-1180","volume":"99","author":"CL Chang","year":"2014","unstructured":"Chang CL, Huang SY, Soong YK, Cheng PJ, Wang CJ, Liang IT. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome. J Clin Endocrinol Metab. 2014;99(12):E2539\u201348. https:\/\/doi.org\/10.1210\/jc.2014-1180.","journal-title":"J Clin Endocrinol Metab"},{"key":"2396_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","volume":"56","author":"S Kralisch","year":"2013","unstructured":"Kralisch S, Fasshauer M. Adipocyte fatty acid binding protein: A novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia. 2013;56:10\u201321. https:\/\/doi.org\/10.1007\/s00125-012-2737-4.","journal-title":"Diabetologia"},{"key":"2396_CR20","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","volume":"274","author":"GS Hotamisligil","year":"1996","unstructured":"Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science. 1996;274:1377\u20139. https:\/\/doi.org\/10.1126\/science.274.5291.1377.","journal-title":"Science"},{"key":"2396_CR21","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","volume":"115","author":"A Xu","year":"2007","unstructured":"Xu A, et al. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: A 5-year prospective study. Circulation. 2007;115:1537\u201343. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.647503.","journal-title":"Circulation"},{"key":"2396_CR22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-07-0102","volume":"157","author":"M M\u00f6hlig","year":"2007","unstructured":"M\u00f6hlig M, et al. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women. Eur J Endocrinol. 2007;157:195\u2013200. https:\/\/doi.org\/10.1530\/EJE-07-0102.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2396_CR23","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jcem-21-11-1440","volume":"21","author":"D Ferriman","year":"1961","unstructured":"Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21(11):1440\u20137. https:\/\/doi.org\/10.1210\/jcem-21-11-1440.","journal-title":"J Clin Endocrinol Metab"},{"key":"2396_CR24","unstructured":"Neyzi O et al. T\u00fcrk \u00e7ocuklar\u0131nda v\u00fccut a\u011f\u0131rl\u0131\u011f\u0131, boy uzunlu\u011fu, ba\u015f \u00e7evresi ve v\u00fccut kitle indeksi referans de\u011ferleri. \u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Dergisi 51.1 (2008): 1\u201314."},{"issue":"6","key":"2396_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000479371","volume":"88","author":"L Ib\u00e1\u00f1ez","year":"2017","unstructured":"Ib\u00e1\u00f1ez L, et al. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Horm Res Paediatr. 2017;88(6):371\u201395. https:\/\/doi.org\/10.1159\/000479371.","journal-title":"Horm Res Paediatr"},{"issue":"8","key":"2396_CR26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1210\/js.2019-00078","volume":"3","author":"SF Witchel","year":"2019","unstructured":"Witchel SF, Oberfield SE, Pe\u00f1a AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls. J Endocr Soc. 2019;3(8):1545\u201373. https:\/\/doi.org\/10.1210\/js.2019-00078.","journal-title":"J Endocr Soc"},{"issue":"2","key":"2396_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.06.035.","journal-title":"Fertil Steril"},{"issue":"8","key":"2396_CR28","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1080\/01443615.2017.1318840","volume":"37","author":"L Li","year":"2017","unstructured":"Li L, Feng Q, Ye M, He Y, Yao A, Shi K. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. J Obstet Gynaecol. 2017;37(8):1036\u201347. https:\/\/doi.org\/10.1080\/01443615.2017.1318840.","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"2396_CR29","first-page":"94","volume":"64","author":"J Kozakowski","year":"2013","unstructured":"Kozakowski J, Zgliczy\u0144ski W. Body composition, glucose metabolism markers and serum androgens - association in women with polycystic ovary syndrome. Endokrynol Pol. 2013;64(2):94\u2013100. PMID: 23653271.","journal-title":"Endokrynol Pol"},{"key":"2396_CR30","doi-asserted-by":"publisher","first-page":"204201882513288","DOI":"10.1177\/2042018825132884","volume":"16","author":"JR Ulloque-Badaracco","year":"2025","unstructured":"Ulloque-Badaracco JR, et al. Triglyceride-glucose index and lipid ratios in women with and without polycystic ovary syndrome: a systematic review and meta-analysis. Ther Adv Endocrinol Metab. 2025;16:20420188251328840. https:\/\/doi.org\/10.1177\/2042018825132884.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"10","key":"2396_CR31","doi-asserted-by":"publisher","first-page":"e0292623","DOI":"10.1371\/journal.pone.0292623","volume":"18","author":"TM Fighera","year":"2023","unstructured":"Fighera TM, Dos Santos BR, Spritzer PM. Lean mass and associated factors in women with PCOS with different phenotypes. PLoS ONE. 2023;18(10):e0292623. https:\/\/doi.org\/10.1371\/journal.pone.0292623.","journal-title":"PLoS ONE"},{"issue":"8","key":"2396_CR32","doi-asserted-by":"publisher","first-page":"e13255","DOI":"10.1111\/obr.13255","volume":"22","author":"M Kazemi","year":"2021","unstructured":"Kazemi M, Pierson RA, Parry SA, Kaviani M, Chilibeck PD. Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: A systematic review and meta-analysis of, 45 observational studies. Obes Rev. 2021;22(8):e13255. https:\/\/doi.org\/10.1111\/obr.13255.","journal-title":"Obes Rev"},{"issue":"12","key":"2396_CR33","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1507\/endocrj.EJ16-0249","volume":"63","author":"A Adamska","year":"2016","unstructured":"Adamska A, et al. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome. Endocr J. 2016;63(12):1107\u201312. https:\/\/doi.org\/10.1507\/endocrj.EJ16-0249.","journal-title":"Endocr J"},{"issue":"7","key":"2396_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3109\/01443615.2016.1174200","volume":"36","author":"R Abali","year":"2016","unstructured":"Abali R, et al. Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome. J Obstet Gynaecol. 2016;36(7):897\u2013901. https:\/\/doi.org\/10.3109\/01443615.2016.1174200.","journal-title":"J Obstet Gynaecol"},{"issue":"2","key":"2396_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5603\/ep.99111","volume":"75","author":"K Paczkowska","year":"2024","unstructured":"Paczkowska K, et al. Circulating levels of irisin and Meteorin-like protein in PCOS and its correlation with metabolic parameters. Endokrynol Pol. 2024;75(2):199\u2013206. https:\/\/doi.org\/10.5603\/ep.99111.","journal-title":"Endokrynol Pol"},{"issue":"2","key":"2396_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s12020-011-9495-9","volume":"40","author":"W Hu","year":"2011","unstructured":"Hu W, Qiao J. Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome. Endocrine. 2011;40(2):196\u2013202. https:\/\/doi.org\/10.1007\/s12020-011-9495-9.","journal-title":"Endocrine"},{"key":"2396_CR37","doi-asserted-by":"publisher","unstructured":"Gormez S et al. Relationships between visceral\/subcutaneous adipose tissue FABP4 expression and coronary atherosclerosis in patients with metabolic syndrome. Cardiovasc Pathol 2020 May-Jun;46:107192. https:\/\/doi.org\/10.1016\/j.carpath.2019.107192.","DOI":"10.1016\/j.carpath.2019.107192"},{"issue":"1","key":"2396_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12905-025-03553-1","volume":"25","author":"MB Ghalehzan","year":"2025","unstructured":"Ghalehzan MB, et al. Polymorphism of the Insulin Resistin (RETN) gene in susceptibility to Polycystic Ovary Syndrome (PCOS) in an Iranian population. BMC Womens Health. 2025;25(1):63. https:\/\/doi.org\/10.1186\/s12905-025-03553-1.","journal-title":"BMC Womens Health"},{"issue":"1","key":"2396_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13098-021-00631-w","volume":"13","author":"Z Majidi","year":"2021","unstructured":"Majidi Z, Emamgholipour S, Omidifar A, Rahmani Fard S, Poustchi H, Shanaki M. The circulating levels of CTRP1 and CTRP5 are associated with obesity indices and carotid intima-media thickness (cIMT) value in patients with type 2 diabetes: a preliminary, study. Diabetol Metab Syndr. 2021;13(1):14. https:\/\/doi.org\/10.1186\/s13098-021-00631-w.","journal-title":"Diabetol Metab Syndr"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02396-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02396-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02396-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:57:18Z","timestamp":1785488238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02396-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2396"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02396-7","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"10 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Erciyes University Faculty of Medicine (Approval No: 2024\/287). The study was conducted in accordance with the principles of the Declaration of Helsinki and relevant institutional guidelines. Written informed consent was obtained from the parents or legal guardians of all participants. In addition, written assent was obtained from all child participants prior to their inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required as this study did not include any identifiable individual data, images, or personal information of the participants.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"218"}}